BDNF and depressive symptom measurement: An impairment of BDNF signaling is involved in the pathophysiology of depression, and mechanisms of BDNF-dependent neuronal plasticity have been consistently implicated in the response to antidepressant medication (reviewed by Castrén and Monteggia, 2021).